<DOC>
	<DOCNO>NCT00395005</DOCNO>
	<brief_summary>Urinary kallikrein excretion know increase patient nephrotic syndrome sick cell disease , decrease patient chronic kidney disease uremia . Some author consider urinary kallikrein marker nephropathy . To evaluate possible role kallikrein kinin system chronic kidney disease , conduct retrospective longitudinal observation study . Patients participate “ Efficacy Pentoxifylline Chronic Kidney Disease ” study include study . The morning spot urinary kallikrein cytokine measure time point 0 12 month addition clinical parameter . The correlation urinary kallikrein cytokine concentration evaluate . Using multiple regression model , relationship urinary kallikrein excretion degree proteinuria , creatinine clearance clinical parameter also evaluate .</brief_summary>
	<brief_title>Correlation Urinary Kallikrein With Cytokines , Proteinuria Renal Function Chronic Renal Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Kallikreins</mesh_term>
	<criteria>During June 2004 June 2005 participate clinical study `` Efficacy Pentoxifylline Chronic Kidney Disease '' ( ClinicalTrials.gov Identifier : NCT00155246 ) sign inform consent . Chronic kidney disease history &gt; 3 month , Serum creatinine : 1.1~6.0 mg/dl female . 1.3~6.2 mg/dl male . Initial Random urine protein ( mg/dl ) /creatinine ( mg/dl ) ratio &gt; 0.5 History allergy pentoxifylline ; female nurse pregnant ; Obstructive uropathy ; Unable stop chronic immunosuppressive therapy , NSAID ; Congestive heart failure ( New York Heart Association functional class III IV ) ; Unstable angina , myocardial infarction , coronary artery bypass graft surgery , percutaneous coronary intervention , within past 6 month prior sign inform consent form ; Cerebral hemorrhage within past 6 month prior sign inform consent form ; Retinal hemorrhage within past 6 month prior sign inform consent form ; Known suspect secondary hypertension ( e.g. , primary aldosteronism , renovascular hypertension , pheochromocytoma ) ; Severe uncontrolled hypertension SBP &gt; 220 mmHg and/or DBP &gt; 115 mmHg ; Hepatic dysfunction define follow laboratory parameter : ALT AST &gt; 2 time upper limit normal range ; Biliary obstructive disorder ( e.g . cholestasis ) ; Active malignancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Kallikrein</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Renal function</keyword>
	<keyword>Chronic kidney disease</keyword>
</DOC>